We are monitoring the impact of COVID-19 on APAC Infectious Diseases Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4452
Share on
Share on

Asia Pacific Infectious Diseases Diagnostics Market Research Report - Segmented By Product, Application, Technology, End-User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC) - Industry Analysis, Size, Share, Growth & Trends Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4452
Pages: 130

APAC Infectious Diseases Diagnostics Market Size (2020 to 2025)

As per the research report, the Asia Pacific Infectious Diseases Diagnostics Market Size is anticipated to grow at 8.98% CAGR from 2020 to 2025. It is estimated that the Asia Pacific market was valued at USD 2.69 billion in 2020 and is relied upon to achieve USD 4.13 billion by 2025.

Y-O-Y growth in the incidence of infectious diseases and the growing acquisition of advanced diagnostic tools in the healthcare system boost the development of the market. Mounting acquisition of advanced molecular procedures, the increasing rate of occurrence of infectious diseases like malaria, flu, and other infections, primarily sexually transmitted diseases like HIV and bacterial infections, are to boost the growth in the region. Few government-based programs in the area offer free screening tests to increase awareness, properly diagnose diseases, and reduce the chances of infections are some factors propelling the market growth in the region.

Immature healthcare infrastructure in underdeveloped countries of the region is hampering the market growth of the area. Adverse and insufficient reimbursement policies hinder the market of infectious disease diagnostics growth during the analysis period in the region.

This research report on the APAC Infectious Diseases Diagnostics Market has been segmented and sub-segmented into the following categories:

By Product: 

  • Instruments
  • Reagents
  • Services
  • Software

By Application: 

  • Hepatitis B
  • Hepatitis C
  • Human Immunodeficiency Virus (HIV)
  • Tuberculosis (TB)
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae (CT/NG)
  • Human papillomavirus (HPV)
  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • and others (Influenza, Ebola, Typhoid, Malaria, and Dengue)

By Technology: 

  • PCR
  • INAAT
  • DNA Sequencing
  • Hybridization

By End User: 

  • Hospital
  • Laboratories

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regional Analysis:

Geographically, Asia-Pacific is projected to register the highest growth rate in the coming years due to the increased pervasiveness of infectious diseases and tremendous investment opportunities due to a growth in healthcare expenditure. Countries belonging to the Asia-Pacific region have the largest share in the infectious disease diagnosis market due to the high prevalence and incidence of infectious diseases, mostly sexually transmitted diseases and bacterial infections.

China is leading to the dominant shares of the market. Factors like mounting awareness of early disease diagnosis and augmenting healthcare providers' investments for healthcare development enhancements stimulate market growth. India is the next leading country after China in the APAC region. Factors like the requirement of stopping the mounting stress of infectious diseases and the government's efforts to improve the healthcare services are mainly anticipated to bolster the market growth in the Asia Pacific. Japan's market is expected to have notable growth in the region due to the launch of new products with the latest technologies.

Notable companies dominating the APAC Infectious Diseases Diagnostics Market profiled in the report are Abbott Laboratories, bioMérieux SA, Hologic, Inc., Danaher Corporation, Becton, Dickinson and Company, Cepheid, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.

1.Introduction                              

                1.1 Market Definition                

                1.2 Study Deliverables              

                1.3 Base Currency, Base Year and Forecast Periods                      

                1.4 General Study Assumptions            

2. Research Methodology                                       

                2.1 Introduction                           

                2.2 Research Phases                  

                                2.2.1 Secondary Research       

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling  

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                     

                2.4 Study Timeline                      

3. Overview                                   

                3.1 Executive Summary            

                3.2 Key Inferences                     

                3.3 Epidemology                          

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                

                4.1 Market Drivers                      

                4.2 Market Restraints                

                4.3 Key Challenges                     

                4.4 Current Opportunities in the Market                          

5. Market Segmentation                                          

                5.1 Product                    

                                5.1.1 Introduction       

                                5.1.2  Instruments & Analyzers                                                 

                                5.1.3 Consumables     

                                                5.1.3.1 Assays and Reagents                                      

                                5.1.4 Services & Softwares      

                                5.1.5  Y-o-Y Growth Analysis, By Product          

                                5.1.6  Market Attractiveness Analysis, By Product        

                                5.1.7  Market Share Analysis, By Product          

                5.2 Technique               

                                5.2.1 Introduction       

                                5.2.2 Traditional Diagnostic Techniques                                                 

                                                5.2.2.1 Immunodiagnostics                                         

                                                5.2.2.2  Microscopy                                        

                                                5.2.2.3 Biochemical Characterization                                       

                                5.2.3 Molecular Diagnostics    

                                                5.2.3.1 PCR                                         

                                                5.2.3.2 INAAT                                    

                                                5.2.3.2 Hybridization                                      

                                                5.2.3.3 DNA Sequencing & NGS                                                

                                                5.2.3.4 Microarray                                           

                                                5.2.3.5 Others                                   

                                5.2.4 Y-o-Y Growth Analysis, By Technique      

                                5.2.5 Market Attractiveness Analysis, By Technique    

                                5.2.6 Market Share Analysis, By Technique      

                5.3 Application             

                                5.3.1 Introduction       

                                5.3.2 Hepatitis B           

                                5.3.3 Hepatitis C           

                                5.3.4 Human Immunodeficiency Virus (HIV)    

                                5.3.5 Tuberculosis (TB)                                                  

                                5.3.6 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG)        

                                5.3.7 Human papillomavirus (HPV)      

                                5.3.8 Methicillin-resistant Staphylococcus aureus (MRSA)        

                                5.3.9 Others  

                                5.3.10 Y-o-Y Growth Analysis, By Application  

                                5.3.11  Market Attractiveness Analysis, By Application                                                   

                                5.3.12  Market Share Analysis, By Application 

                5.4 End User                  

                                5.4.1 Introduction       

                                5.4.2 Hospitals  Laboratories   

                                5.4.3 Physician office Labs       

                                5.4.4  Academics          

                                5.4.5 Others  

                                5.4.6 Y-o-Y Growth Analysis, By End User         

                                5.4.7  Market Attractiveness Analysis, By End User      

                                5.4.8  Market Share Analysis, By End User        

6. Geographical Analysis                                          

                6.1 Introduction                           

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis 

                                6.1.3 Y-o-Y Growth Analysis    

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Product                                           

                                                6.1.3.3 By Technique                                     

                                                6.1.3.4 By Application                                    

                                                6.1.3.5 By End User                                        

                                6.1.4  Market Attractiveness Analysis 

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Product                                           

                                                6.1.4.3 By Technique                                     

                                                6.1.4.4 By Application                                    

                                                6.1.4.5 By End User                                        

                                6.1.5  Market Share Analysis  

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Product                                           

                                                6.1.5.3 By Technique                                     

                                                6.1.5.4 By Application                                    

                                                6.1.5.5 By End User                                        

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia      

7. Strategic Analysis                                   

                7.1 PESTLE analysis                     

                                7.1.1 Political 

                                7.1.2 Economic                                                 

                                7.1.3 Social     

                                7.1.4 Technological     

                                7.1.5 Legal      

                                7.1.6 Environmental   

                7.2 Porter’s Five analysis                          

                                7.2.1 Bargaining Power of Suppliers    

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants 

                                7.2.4 Threat of Substitute Products and Services          

                                7.2.5 Competitive Rivalry within the Industry 

8. Market Leaders' Analysis                                    

                8.1 Abbott Laboratories           

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments   

                                8.1.5 SWOT analysis   

                                8.1.6 Analyst View      

                8.2 bioMérieux SA                      &

 

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of by Product, Application, Technology and End User along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Asia Pacific Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Infectious Diseases Diagnostics Market, By Product, From 2020 to 2025 (USD Billion)
  2. Asia Pacific Instruments Market, By Region, From 2020 to 2025 (USD Billion)
  3. Asia Pacific Reagents Market, By Region, From 2020 to 2025 (USD Billion)
  4. Asia Pacific Services Market, By Region, From 2020 to 2025 (USD Billion)
  5. Asia Pacific Software Market, By Region, From 2020 to 2025 (USD Billion)
  6. Asia Pacific Infectious Diseases Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  7. Asia Pacific Hepatitis B Market, By Region, From 2020 to 2025 (USD Billion)
  8. Asia Pacific Hepatitis C Market, By Region, From 2020 to 2025 (USD Billion)
  9. Asia Pacific Human Immunodeficiency Virus (HIV) Market, By Region, From 2020 to 2025 (USD Billion)
  10. Asia Pacific Tuberculosis (TB) Market, By Region, From 2020 to 2025 (USD Billion)
  11. Asia Pacific Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) Market, By Region, From 2020 to 2025 (USD Billion)
  12. Asia Pacific human papillomavirus (HPV) Market, By Region, From 2020 to 2025 (USD Billion)
  13. Asia Pacific Methicillin-resistant Staphylococcus aureus (MRSA) Market, By Region, From 2020 to 2025 (USD Billion)
  14. Asia Pacific Infectious Diseases Diagnostics Market, By Technology, From 2020 to 2025 (USD Billion)
  15. Asia Pacific PCR Market, By Region, From 2020 to 2025 (USD Billion)
  16. Asia Pacific INAAT Market, By Region, From 2020 to 2025 (USD Billion)
  17. Asia Pacific DNA Sequencing Market, By Region, From 2020 to 2025 (USD Billion)
  18. Asia Pacific Hybridization Market, By Region, From 2020 to 2025 (USD Billion)
  19. Asia Pacific Infectious Diseases Diagnostics Market, By End User, From 2020 to 2025 (USD Billion)
  20. Asia Pacific Laboratories Market, By Region, From 2020 to 2025 (USD Billion)
  21. Asia Pacific Hospital Market, By Region, From 2020 to 2025 (USD Billion)
  22. Japan Infectious Diseases Diagnostics Market, By Product, From 2020 to 2025 (USD Billion)
  23. Japan Infectious Diseases Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  24. Japan Infectious Diseases Diagnostics Market, By Technology, From 2020 to 2025 (USD Billion)
  25. Japan Infectious Diseases Diagnostics Market, By End User, From 2020 to 2025 (USD Billion)
  26. China Infectious Diseases Diagnostics Market, By Product, From 2020 to 2025 (USD Billion)
  27. China Infectious Diseases Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  28. China Infectious Diseases Diagnostics Market, By Technology, From 2020 to 2025 (USD Billion)
  29. China Infectious Diseases Diagnostics Market, By End User, From 2020 to 2025 (USD Billion)
  30. India Infectious Diseases Diagnostics Market, By Product, From 2020 to 2025 (USD Billion)
  31. India Infectious Diseases Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  32. India Infectious Diseases Diagnostics Market, By Technology, From 2020 to 2025 (USD Billion)
  33. India Infectious Diseases Diagnostics Market, By End User, From 2020 to 2025 (USD Billion)
  34. Australia Infectious Diseases Diagnostics Market, By Product, From 2020 to 2025 (USD Billion)
  35. Australia Infectious Diseases Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  36. Australia Infectious Diseases Diagnostics Market, By Technology, From 2020 to 2025 (USD Billion)
  37. Australia Infectious Diseases Diagnostics Market, By End User, From 2020 to 2025 (USD Billion)
  38. South Korea Infectious Diseases Diagnostics Market, By Product, From 2020 to 2025 (USD Billion)
  39. South Korea Infectious Diseases Diagnostics Market, By Application, From 2020 to 2025 (USD Billion)
  40. South Korea Infectious Diseases Diagnostics Market, By Technology, From 2020 to 2025 (USD Billion)
  41. South Korea Infectious Diseases Diagnostics Market, By End User, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample